Drug Trials News for March 2021

CHMP Adopts Positive Opinion for Evrysdi™ for the Treatment of Spinal Muscular Atrophy in Adults and Children Aged Two Months and Older CHMP Adopts Positive Opinion for Evrysdi™ for the Treatment of Spinal Muscular Atrophy in Adults and Children Aged Two Months and Older

Evrysdi is the first and only at-home treatment for SMA patients. Opinion based on efficacy results from the FIREFISH and SUNFISH pivotal trials –
04 March, 2021